Congenital Heart Futures Reauthorization Act of 2024

[118th Congress Public Law 107]
[From the U.S. Government Publishing Office]



[[Page 138 STAT. 1594]]

Public Law 118-107
118th Congress

                                 An Act


 
    To amend the Public Health Service Act to reauthorize a national 
congenital heart disease research, surveillance, and awareness program, 
     and for other purposes. <<NOTE: Nov. 21, 2024 -  [H.R. 7189]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, <<NOTE: Congenital Heart 
Futures Reauthorization Act of 2024.>> 
SECTION 1. <<NOTE: 42 USC 201 note.>>  SHORT TITLE.

    This Act may be cited as the ``Congenital Heart Futures 
Reauthorization Act of 2024''.
SEC. 2. REAUTHORIZATION OF NATIONAL CONGENITAL HEART DISEASE 
                    RESEARCH, SURVEILLANCE, AND AWARENESS PROGRAM.

     Section 399V-2 of the Public Health Service Act (42 U.S.C. 280g-13) 
is amended--
            (1) by redesignating subsections (f) and (g) as subsections 
        (g) and (h), respectively;
            (2) by inserting after subsection (e) the following:

    ``(f) Report and Strategy.--
            ``(1) Report.--Not later than 2 years after the date of 
        enactment of the Congenital Heart Futures Reauthorization Act of 
        2024, the Secretary shall issue a report to the Committee on 
        Energy and Commerce of the House of Representatives and the 
        Committee on Health, Education, Labor, and Pensions of the 
        Senate including the following:
                    ``(A) A description of past and present activities 
                of the Department of Health and Human Services to 
                increase awareness and knowledge of the public with 
                respect to congenital heart disease, including efforts 
                to address the lifelong needs of congenital heart 
                disease patients.
                    ``(B) <<NOTE: Assessment.>>  An assessment of past 
                and present activities of the Department of Health and 
                Human Services to increase education and training of 
                health care providers with respect to congenital heart 
                disease, including efforts to address the lifelong needs 
                of congenital heart disease patients.
                    ``(C) A description of the current workforce 
                capacity in the United States of health care providers 
                who treat adult patients living with congenital heart 
                disease.
            ``(2) Strategy.--
                    ``(A) Development; submission to congress.--Not 
                later than 1 year after submitting the report required 
                by paragraph (1), the Secretary shall develop and submit 
                to Congress a strategy for improving efforts to increase 
                awareness and knowledge of the public and education and 
                training of health care providers with respect to 
                congenital

[[Page 138 STAT. 1595]]

                heart disease. <<NOTE: Recommenda- tions.>>  Such 
                strategy shall include findings and recommendations to--
                          ``(i) address any public awareness and 
                      research gaps and opportunities related to the 
                      lifelong needs of congenital heart disease 
                      patients, including long-term health outcomes, 
                      quality of life, mental health, and health care 
                      utilization;
                          ``(ii) address any shortages in the current 
                      workforce of health care providers who treat adult 
                      patients living with congenital heart disease, 
                      which may include strategies to enhance fellowship 
                      training programs or other continuing education 
                      programs; and
                          ``(iii) foster collaboration and dissemination 
                      of information across Federal agencies, health 
                      care providers, researchers, and patient 
                      organizations.
                    ``(B) Consultation.--In developing the strategy 
                under subparagraph (A), the Secretary shall, as 
                appropriate, consult with qualified stakeholder groups, 
                including patient organizations, health care 
                professionals, research entities, health insurance 
                providers, accrediting organizations, and relevant 
                Federal agencies, including the Centers for Disease 
                Control and Prevention, the National Institutes of 
                Health, and the Health Resources and Services 
                Administration.''; and
            (3) in subsection (h), as so redesignated, by striking 
        ``2020 through 2024'' and inserting ``2025 through 2029''.

    Approved November 21, 2024.

LEGISLATIVE HISTORY--H.R. 7189:
---------------------------------------------------------------------------

HOUSE REPORTS: No. 118-517 (Comm. on Energy and Commerce).
CONGRESSIONAL RECORD, Vol. 170 (2024):
            Sept. 23, considered and passed House.
            Sept. 25, considered and passed Senate.

                                  <all>